SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-09-083139
Filing Date
2009-04-21
Accepted
2009-04-21 09:56:18
Documents
6
Period of Report
2009-06-05
Effectiveness Date
2009-04-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 593327
2 GRAPHIC g34548g15f87.jpg GRAPHIC 9078
3 GRAPHIC g34548g80n92.jpg GRAPHIC 6975
4 GRAPHIC g34548g97s96.jpg GRAPHIC 15789
5 GRAPHIC g34548pc_pg001new.jpg GRAPHIC 181246
6 GRAPHIC g34548pc_pg002new.jpg GRAPHIC 100198
  Complete submission text file 0001193125-09-083139.txt   1027171
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31577 | Film No.: 09760663
SIC: 2834 Pharmaceutical Preparations